kandeel, E., Y. Madney, R. Amin, and A. Kamel, "Role of Minimal Residual Disease in the Clinical Course of T cell Acute Lymphoblastic Leukemia in Pediatric Patients", J Leuk 7 , vol. 7, pp. 256., 2019.
kandeel, E., Y. Madney, R. Amin, and A. Kamel, "Role of Minimal Residual Disease in the Clinical Course of T cell Acute Lymphoblastic Leukemia in Pediatric Patients", J Leuk 7 , vol. 7, pp. 256., 2019.
Kamel, A. M., N. A. H. L. A. M.ELSHARKAWY, Eman Z. Kandeel, M. Hanafi, M. Samra, and R. A. Osman, "Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia", Frontiers in Oncology , vol. 12, pp. 867684-867684, 2022.
Kandeel, E. Z., L. Refaat, R. Abdel-Fatah, M. Samra, A. Bayoumi, M. S. Abdellateif, H. Abdel-Hady, M. Ali, and medhat khafagy, ""Could COVID-19 induce remission of acute leukemia?.3.", Hematology, vol. 26, issue 1, pp. 870-873., 2021.
Maha, S., M. Khali, M. S. Abdellateif, E. Ebeid, Y. madney, and E. Z. Kandeel, "Role of matrix metalloproteinase MMP-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP-1) in the clinical progression of pediatric acute lymphoblastic leukemia", Hematology, vol. 26, issue 1, pp. 758-768., 2021.
kandeel e, Y. madney, Dalia Negm Eldin, and N. F. Shafik, "Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia", Experimental and Molecular Pathology, vol. 118 (2021): 104597., pp. 104597., 2021.
kandeel e, E. N, H. M, S. M, and kamel A, "Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia", Clin Lymphoma Myeloma Leuk, vol. Jun;2020, issue 6, pp. 383-393, 2020.
S, A. - A., E. S. A. Gaber O, M. D, A. M, K. EZ, and E. I, " FLT3-ITD Mutations in Egyptian Patients of Acute Myeloid Leukemia: Correlation with Cytogenetic, FAB Subgroups and Prognosis", Clin Lab, vol. May(1)63, issue 5, pp. 1027-1034, 2017.
MS, A., S. SM, E. - H. AH, S. ML, E. - H. ME, and K. EZ, "A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell-dendritic cell-based vaccine", Oncol Lett., vol. july, issue 16, pp. 529-535, 2018.
EZ, K., E. S. G, E. N, N. HR, I. D, A. R, H. M, K. M, and Kamel, M.M., "Impact of FLT3 Receptor (CD135) Detection by Flow Cytometry on Clinical Outcome of Adult Acute Myeloid Leukemia Patients", Clin Lymphoma Myeloma Leuk, vol. 18, issue 8, pp. 541-547, 2018.
Tourism